Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial.
Kendler DL, Marin F, Zerbini CAF, Russo LA, Greenspan SL, Zikan V, Bagur A, Malouf-Sierra J, Lakatos P, Fahrleitner-Pammer A, Lespessailles E, Minisola S, Body JJ, Geusens P, Möricke R, López-Romero P.
Lancet. 2018 Jan 20;391(10117):230-240. doi: 10.1016/S0140-6736(17)32137-2. Epub 2017 Nov 9.
PMID:29129436
Management of severe osteoporosis.
Miller PD.
Expert Opin Pharmacother. 2016;17(4):473-88. doi: 10.1517/14656566.2016.1124856. Epub 2015 Dec 23.
PMID:26605922
Current Status of the Diagnosis and Management of Osteoporosis.
Aibar-Almazán A, Voltes-Martínez A, Castellote-Caballero Y, Afanador-Restrepo DF, Carcelén-Fraile MDC, López-Ruiz E.
Int J Mol Sci. 2022 Aug 21;23(16):9465. doi: 10.3390/ijms23169465.
PMID:36012730
Update on Osteoporosis Screening and Management.
Anam AK, Insogna K.
Med Clin North Am. 2021 Nov;105(6):1117-1134. doi: 10.1016/j.mcna.2021.05.016. Epub 2021 Sep 8.
PMID:34688418
Osteoporosis. Definition and clinical presentation.
Glaser DL, Kaplan FS.
Spine (Phila Pa 1976). 1997 Dec 15;22(24 Suppl):12S-16S. doi: 10.1097/00007632-199712151-00003.
PMID:9431639
Clinical effects of teriparatide, abaloparatide, and romosozumab in postmenopausal osteoporosis.